Welcome to LookChem.com Sign In|Join Free

CAS

  • or

1055943-40-2

Post Buying Request

1055943-40-2 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

1055943-40-2 Usage

General Description

(E)-4-(dimethylamino)but-2-enoyl chloride is a chemical compound with the molecular formula C8H14ClNO. It is a yellowish liquid that is used as an intermediate in the synthesis of pharmaceuticals, dyes, and other organic compounds. (E)-4-(diMethylaMino)but-2-enoyl chloride has a reactive acyl chloride functional group, which makes it useful in organic reactions such as acylation and amidation. It is also known for its role as a key reagent in the synthesis of various heterocyclic compounds. Additionally, (E)-4-(dimethylamino)but-2-enoyl chloride is used in the development of new materials and as a building block in organic chemistry research. Due to its versatile nature, this compound is commonly used in the pharmaceutical and chemical industries for various applications.

Check Digit Verification of cas no

The CAS Registry Mumber 1055943-40-2 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,0,5,5,9,4 and 3 respectively; the second part has 2 digits, 4 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 1055943-40:
(9*1)+(8*0)+(7*5)+(6*5)+(5*9)+(4*4)+(3*3)+(2*4)+(1*0)=152
152 % 10 = 2
So 1055943-40-2 is a valid CAS Registry Number.

1055943-40-2SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 19, 2017

Revision Date: Aug 19, 2017

1.Identification

1.1 GHS Product identifier

Product name ((E)-4-dimethylamino)-crotonyl chloride hydrochloride

1.2 Other means of identification

Product number -
Other names .4-dimethylaminocrotonoyl chloride hydrochloride

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:1055943-40-2 SDS

1055943-40-2Relevant articles and documents

Preparation method of neratinib

-

Page/Page column 10-11, (2019/11/04)

The invention relates to a preparation method of neratinib. The preparation method specifically comprises the steps: (1) in an organic solvent 1, trans-4-dimethylaminocrotonic acid hydrochloride and achloride agent react, and thus a solution containing (e)-4-(dimethylamino)but-2-enoyl chloride (hydrochloride) is obtained; (2) a solution of an organic solvent 2 containing 6-amino-4-[[3-chloro-4-[(pyridine-2-yl)methoxy]phenyl]amino]-3-cyano-7-ethoxyquinoline is added into the solution obtained in the step (1) to react, and then neratinib hydrochloride is obtained; and (3) the neratinib hydrochloride obtained in the step (2) is mixed with water and an organic solvent 3, a reaction is carried out after the pH value is regulated to be 7-10, and then the neratinib is obtained. The synthesis method has the advantages that the yield is high, the product purity is high, the production cost is low, operation is safe, easy and convenient, and large-scale industrial production is easy.

QUINAZOLINE DERIVATIVE, PREPARATION METHOD THEREFOR, AND PHARMACEUTICAL COMPOSITION AND APPLICATION THEREOF

-

Paragraph 0134; 0138, (2017/07/14)

Disclosed are a quinazoline derivative, a preparation method therefor, and a pharmaceutical composition and an application thereof. The present invention provides a compound represented by general formula I, a stereoisomer thereof and a pharmaceutical acceptable salt or a solvate thereof. The quinazoline derivative of the present invention has a unique chemical structure, is characterized by irreversibly inhibiting EGFR tyrosine kinase, has high biological activity, apparently improves the inhibiting effect on the EGFR tyrosine kinase, has quite strong tumor inhibiting effect on tumor cells and a transplantation tumor pathological model of animal tumors, and has good market developing prospects.

Method for purifying neratinib

-

Paragraph 0032; 0034-0035, (2017/04/14)

The invention relates to a method for purifying neratinib. The method provided by the invention is capable of effectively reducing the content of impurities in neratinib and preparing high-purity neratinib, and moreover is simple in operation, high in yield and very applicable to industrial production.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 1055943-40-2